190 related articles for article (PubMed ID: 7525612)
21. Influence of cell type on the steroidogenic potential and basal cyclic AMP levels of ras-oncogene-transformed rat cells.
Pan J; Roskelley CD; Auersperg N
Differentiation; 1995 Jun; 58(5):321-8. PubMed ID: 7622009
[TBL] [Abstract][Full Text] [Related]
22. Basic fibroblast growth factor selectively regulates ornithine decarboxylase gene expression in malignant H-ras transformed cells.
Hurta RA; Huang A; Wright JA
J Cell Biochem; 1996 Mar; 60(4):572-83. PubMed ID: 8707896
[TBL] [Abstract][Full Text] [Related]
23. Involvement of cAMP and calcium in the induction of ornithine decarboxylase activity in an osteoblast cell line.
van Leeuwen JP; Bos MP; Herrmann-Erlee MP
J Cell Physiol; 1988 Jun; 135(3):488-94. PubMed ID: 2840435
[TBL] [Abstract][Full Text] [Related]
24. Mechanism of the impairment of the glucagon-stimulated phosphoenolpyruvate carboxykinase gene expression by interleukin-6 in rat hepatocytes: inhibition of the increase in cyclic 3',5' adenosine monophosphate and the downstream cyclic 3',5' adenosine monophosphate action.
Christ B; Nath A; Jungermann K
Hepatology; 1997 Jul; 26(1):73-80. PubMed ID: 9214454
[TBL] [Abstract][Full Text] [Related]
25. Translation of ODC mRNA and polyamine transport are suppressed in ras-transformed CREF cells by depleting translation initiation factor 4E.
Graff JR; De Benedetti A; Olson JW; Tamez P; Casero RA; Zimmer SG
Biochem Biophys Res Commun; 1997 Nov; 240(1):15-20. PubMed ID: 9367873
[TBL] [Abstract][Full Text] [Related]
26. SCH 51344 inhibits ras transformation by a novel mechanism.
Kumar CC; Prorock-Rogers C; Kelly J; Dong Z; Lin JJ; Armstrong L; Kung HF; Weber MJ; Afonso A
Cancer Res; 1995 Nov; 55(21):5106-17. PubMed ID: 7585559
[TBL] [Abstract][Full Text] [Related]
27. A role for protein kinase C-delta in the regulation of ornithine decarboxylase expression by oxidative stress.
Otieno MA; Kensler TW
Cancer Res; 2000 Aug; 60(16):4391-6. PubMed ID: 10969783
[TBL] [Abstract][Full Text] [Related]
28. Malignant transformation by H-ras results in aberrant regulation of ribonucleotide reductase gene expression by transforming growth factor-beta 1.
Hurta RA; Wright JA
J Cell Biochem; 1995 Mar; 57(3):543-56. PubMed ID: 7768988
[TBL] [Abstract][Full Text] [Related]
29. Elevated levels of ornithine decarboxylase cooperate with Raf/ERK activation to convert normal keratinocytes into invasive malignant cells.
Hayes CS; DeFeo K; Lan L; Paul B; Sell C; Gilmour SK
Oncogene; 2006 Mar; 25(10):1543-53. PubMed ID: 16278677
[TBL] [Abstract][Full Text] [Related]
30. cAMP-mediated signals as determinants for apoptosis in primary granulosa cells.
Aharoni D; Dantes A; Oren M; Amsterdam A
Exp Cell Res; 1995 May; 218(1):271-82. PubMed ID: 7537693
[TBL] [Abstract][Full Text] [Related]
31. Genetic evidence that a phorbol ester tumor promoter stimulates ornithine decarboxylase activity by a pathway that is independent of cyclic AMP-dependent protein kinases in CHO cells.
Lichti U; Gottesman MM
J Cell Physiol; 1982 Dec; 113(3):433-9. PubMed ID: 6294128
[TBL] [Abstract][Full Text] [Related]
32. ras downregulation of protein kinase C mRNA in C3H 10T1/2 fibroblasts.
Fernandes ER; Ashendel CL
Mol Carcinog; 1996 Sep; 17(1):23-34. PubMed ID: 8876672
[TBL] [Abstract][Full Text] [Related]
33. Requirements for and kinetics of growth arrest of neoplastic cells by confluent 10T1/2 fibroblasts induced by a specific inhibitor of cyclic adenosine 3':5'-phosphodiesterase.
Bertram JS; Faletto MB
Cancer Res; 1985 May; 45(5):1946-52. PubMed ID: 2985240
[TBL] [Abstract][Full Text] [Related]
34. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
Larcher F; Robles AI; Duran H; Murillas R; Quintanilla M; Cano A; Conti CJ; Jorcano JL
Cancer Res; 1996 Dec; 56(23):5391-6. PubMed ID: 8968091
[TBL] [Abstract][Full Text] [Related]
35. Expression of an ornithine decarboxylase dominant-negative mutant reverses eukaryotic initiation factor 4E-induced cell transformation.
Shantz LM; Coleman CS; Pegg AE
Cancer Res; 1996 Nov; 56(22):5136-40. PubMed ID: 8912847
[TBL] [Abstract][Full Text] [Related]
36. Transformation of NIH/3T3 cells by ornithine decarboxylase overexpression.
Moshier JA; Dosescu J; Skunca M; Luk GD
Cancer Res; 1993 Jun; 53(11):2618-22. PubMed ID: 8495425
[TBL] [Abstract][Full Text] [Related]
37. Influence of exogenous ras and p53 on P-glycoprotein function in immortalized rodent fibroblasts.
Kopnin BP; Stromskaya TP; Kondratov RV; Ossovskaya VS; Pugacheva EN; Rybalkina EY; Khokhlova OA; Chumakov PM
Oncol Res; 1995; 7(6):299-306. PubMed ID: 8527864
[TBL] [Abstract][Full Text] [Related]
38. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
Su ZZ; Austin VN; Zimmer SG; Fisher PB
Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of ornithine decarboxylase (ODC) decreases tumor vascularization and reverses spontaneous tumors in ODC/Ras transgenic mice.
Lan L; Trempus C; Gilmour SK
Cancer Res; 2000 Oct; 60(20):5696-703. PubMed ID: 11059762
[TBL] [Abstract][Full Text] [Related]
40. Regulation of two forms of the TNF receptors by phorbol ester and dibutyryl cyclic adenosine 3',5'-monophosphate in human histiocytic lymphoma cell line U-937.
Aggarwal BB; Graff K; Samal B; Higuchi M; Liao WS
Lymphokine Cytokine Res; 1993 Jun; 12(3):149-58. PubMed ID: 7688579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
